Prevalence of Cardiac Diastolic Dysfunction in HIV-Infected Patients: Results of the HIV-HEART Study

REFERENCES

• Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–860.
   PubMed Web of Science ®Google Scholar
• Koutkia P, Grinspoon S. HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversies. Ann Rev Med. 2004;55:303–317.
   PubMed Web of Science ®Google Scholar
• Mocroft A, Ledergerber B, Katlama C, et al; EuroSIDA study group. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362:22–29.
   PubMed Web of Science ®Google Scholar
• Früs-Moller N, Weber R, Reiss P, et al; D:A:D study group. Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the D:A:D study. AIDS. 2003;17:1179–1193.
   PubMed Web of Science ®Google Scholar
• D:A:D Study Group; Früs-Moller N, Reiss P, Sabin CA, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356:1723–1735.
   PubMed Web of Science ®Google Scholar
• Nayak G, Ferguson M, Tribble DR, Porter CK, Rapena R, Marchicelli M, Decker CF. Cardiac diastolic dysfunction is prevalent in HIV-infected patients. AIDS Patient Care STDS. 2009;23:231–238.
   PubMed Web of Science ®Google Scholar
• Kuznetsova T, Herbots L, Lopez B, et al. Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail. 2009;2:105–112.
   PubMed Web of Science ®Google Scholar
• Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Conges-tive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998;98:2282–2289.
   PubMed Web of Science ®Google Scholar
• Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll CardioL 2004;43: 317–327.
   PubMed Web of Science ®Google Scholar
• Redfield MM, Jacobsen SJ, Burnett JO Jr, Mahoney DW, Bailey KR, Rodeheller RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. J Am Med Assoc. 2003;289:194–202.
   PubMed Web of Science ®Google Scholar
• Rusconi C, Sabatini T, Faggiano P, et al. Prevalence of iso-lated left ventricular diastolic dysfunction in hypertension as assessed by combined transmitral and pulmonary vein flow Doppler study. Am J Cardiol. 2001;87:357–360.
   PubMed Web of Science ®Google Scholar
• Neumann T, Esser S, Potthoff A, et al. Prevalence and natural history of heart failure in outpatient HIV-infected subjects: rationale and design of the HIV-HEART study. Eur J Med Res. 2007;12:243–248.
   PubMed Web of Science ®Google Scholar
• Otto C. Transthoracic views, normal anatomy, and flow patterns. In: Textbook of Clinical Echocardiography. 3rd ed. Philadelphia: Elsevier Saunders; 2004.
   Google Scholar
• Cheitlin MD, Armstrong WF, Aurigemma GP, et al; ACC; AHA; ASE. ACC/AHA/ASE 2003. Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/ AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr 2003;16:1091–1110.
   PubMed Web of Science ®Google Scholar
• Erbel R, Schweizer P, Henn G, Meyer J, Effert S. Apical two-dimensional echocardiography: normal values for sin-gle- and bi-plane determination of left ventricular volume and ejection fraction. Deutsche Medizinische Wochen-schrift. 1982;107:1872–1877.
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, et al; Chamber Quanti-fication Writing Group; American Society of Echocardiog-raphy's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440–1463.
   PubMed Web of Science ®Google Scholar
• European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J. 1998;19:990–1003.
   PubMed Web of Science ®Google Scholar
• Galderisi M. Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects. Cardiovasc Ultrasound. 2005;3:9.
   PubMedGoogle Scholar
• Zile MR, Brutsaert DL. New concepts in diastolic dysfunc-tion and diastolic heart failure: Part k Diagnosis, progno-sis, and measurements of diastolic function. Circulation. 2002;105:1387–1393.
   PubMed Web of Science ®Google Scholar
• Fischer M, Baessler A, Hense HW, et al. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J. 2003;24:320–328.
   PubMed Web of Science ®Google Scholar
• Zile MR, Brutsaert DL. New concepts in diastolic dysfunc-tion and diastolic heart failure: Part II: Causal mechanisms and treatment. Circulation. 2002;105:1503–1508.
   PubMed Web of Science ®Google Scholar
• Annonu AK, Fattah AA, Mokhtar MS, Ghareeb S, Elhendy A. Left ventricular systolic and diastolic func-tional abnormalities in asymptomatic patients with non-insulindependent diabetes mellitus. J Am Soc Echocardiogr 200114: 885–891.
   Google Scholar
• D:A:D Study Group. Use of nucleoside reverse tran-scriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet. 2008;371: 1417–1426.
   PubMed Web of Science ®Google Scholar
• Schuster I, Thöni GJ, Edérhy S, et al. Subclinical car-diac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy. Am J Cardiol. 2008;101:1213–1217.
   PubMed Web of Science ®Google Scholar
• Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. New Engl J Med. 2005;352:48–62.
   PubMed Web of Science ®Google Scholar
• Meng Q, Lima JA, Lai H, et al. Use of HIV protease inhibi-tors is associated with left ventricular morphologic changes and diastolic dysfunction. J Acquir Immune Defic Syndr. 2002;30:306–310.
   PubMed Web of Science ®Google Scholar
• Strategies for Management of Antiretroviral Therapy (SMART) Study Group; El-Sadr WM, Lundgren JD, Neaton JD, et al. CD4+ count-guided interruption of antiretroviral therapy. N Engl J Med. 2006;355:2283–2296.
   PubMed Web of Science ®Google Scholar
• Torriani FJ, Komarow L, Parker RA, et al. Endothelial function in human immunodeficiency virus-infected anti-retroviral-naive subjects before and after starting potent antiretroviral therapy: the ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol. 2008;52:569–576.
   PubMed Web of Science ®Google Scholar
• Herskowitz A, Vlahov D, Willoughby S, Chaisson RE, Schulman SP, Neumann DA, Baughman KL. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. Am J Cardiol. 1993;71:955–958.
   PubMed Web of Science ®Google Scholar